PFIZER INC Gain (Loss) on Sale of Properties
PFIZER INC (PFE) reported Gain (Loss) on Sale of Properties of -$420.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:GainLossOnSaleOfProperties · last filed 2026-02-26
- PFIZER INC gain (loss) on sale of properties for the quarter ending 2024-12-31 was $0.00.
- PFIZER INC gain (loss) on sale of properties for the quarter ending 2024-09-29 was -$420.00M.
- PFIZER INC gain (loss) on sale of properties for fiscal 2024 was -$420.00M.
| Period end | Gain (Loss) on Sale of Properties 3 month | Gain (Loss) on Sale of Properties 6 month | Gain (Loss) on Sale of Properties 9 month | Gain (Loss) on Sale of Properties 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$420.00M derived: sum of 2 quarters · filed 2026-02-26 | -$420.00M 10-K · filed 2026-02-26 | |
| 2024-09-29 | -$420.00M 10-Q · filed 2025-11-04 | -$420.00M 10-Q · filed 2025-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |